Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02719613
Title Continuing Treatment for Subjects Who Have Participated in a Prior Protocol Investigating Elotuzumab
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 0020 Tucson Arizona 85715 United States Details
Comprehensive Blood And Cancer Center Bakersfield California 93309 United States Details
Robert A. Moss, Md Facp, Inc. Fountain Valley California 92708 United States Details
Local Institution - 0016 West Hollywood California 90069 United States Details
Rocky Mountain Cancer Centers (Williams) - USOR Denver Colorado 80218 United States Details
Local Institution - 0021 Jacksonville Florida 32256 United States Details
Florida Cancer Specialists - North Saint Petersburg Florida 33705 United States Details
Emory University Atlanta Georgia 30322 United States Details
University Of Chicago Medical Center Chicago Illinois 60637 United States Details
Investigative Clinical Research Of Indiana, Llc Indianapolis Indiana 46260 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Local Institution - 0008 Saint Louis Missouri 63110 United States Details
Icahn School Of Medicine At Mount Sinai New York New York 10029 United States Details
St. Luke's University Health Network Bethlehem Pennsylvania 18015 United States Details
Texas Oncology Dallas Texas 75231 United States Details
Local Institution Heidelberg Victoria 3084 Australia Details
Local Institution Antwerpen 2060 Belgium Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0011 Toronto Ontario M5G 2M9 Canada Details
Local Institution Halifax B3H 2Y9 Canada Details
Local Institution Athens 11528 Greece Details
Local Institution - 0036 Budapest 1097 Hungary Details
Local Institution Ancona 60126 Italy Details
Local Institution Firenze 50134 Italy Details
Local Institution Genova 16132 Italy Details
Local Institution Torino 10126 Italy Details
Local Institution - 0046 Aomori-shi Aomori 0308553 Japan Details
Local Institution Shibukawa-shi Gunma 3770280 Japan Details
Local Institution Osaka-shi Osaka 5300012 Japan Details
Local Institution Koto-ku Tokyo 135-8550 Japan Details
Local Institution - 0050 Chiba 260-8677 Japan Details
Local Institution Kasama-shi 3091793 Japan Details
Local Institution Chorzow 41-500 Poland Details
Local Institution - 0026 Warszawa 02-106 Poland Details
Local Institution - 0039 Warszawa 02-776 Poland Details
Local Institution Bucuresti 030171 Romania Details
Local Institution - 0029 Iasi 700483 Romania Details
Local Institution - 0040 Salamanca 37007 Spain Details
Local Institution Toledo 45004 Spain Details
Local Institution - 0031 Cebeci Ankara 06620 Turkey Details
Local Institution London EC1A 7BE United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field